Broad-spectrum peptide inhibitors of aminoglycoside antibiotic resistance enzymes

Chem Biol. 2003 Feb;10(2):189-96. doi: 10.1016/s1074-5521(03)00026-7.

Abstract

The action of aminoglycoside antibiotics is inhibited by chemical modification catalyzed by aminoglycoside inactivating enzymes, which bind these cationic saccharides with active site pockets that contain a preponderance of negatively charged residues. In this study, it was observed that several cationic antimicrobial peptides, representing different structural classes, could serve as inhibitors of such aminoglycoside resistance enzymes. The bovine antimicrobial peptide indolicidin and synthetic analogs appeared to be especially effective against a range of resistance enzymes, inhibiting enzymes belonging to both aminoglycoside phosphotransferase and aminoglycoside acetyltransferase classes, where the mode of action was dependent on the class of antibiotic resistance enzyme. These peptides represent the first example of broad-spectrum inhibitors of aminoglycoside resistance enzymes.

Publication types

  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Acetyltransferases / antagonists & inhibitors
  • Algorithms
  • Aminoglycosides
  • Anti-Bacterial Agents / chemistry
  • Anti-Bacterial Agents / pharmacology*
  • Antimicrobial Cationic Peptides / chemistry
  • Antimicrobial Cationic Peptides / pharmacology
  • Bacteria / drug effects*
  • Bacteria / enzymology*
  • Drug Resistance, Bacterial / physiology*
  • Kanamycin Kinase / antagonists & inhibitors
  • Nucleotidyltransferases / antagonists & inhibitors
  • Peptides / chemical synthesis
  • Peptides / chemistry
  • Peptides / pharmacology*
  • Structure-Activity Relationship

Substances

  • Aminoglycosides
  • Anti-Bacterial Agents
  • Antimicrobial Cationic Peptides
  • Peptides
  • indolicidin
  • Acetyltransferases
  • aminoglycoside acetyltransferase
  • Kanamycin Kinase
  • Nucleotidyltransferases
  • gentamicin 2''-nucleotidyltransferase